Get the Stockscreener App
0.1482
1.92%
-0.0029
After Hours:
.15
0.0018
+1.21%
In 8 Bio Inc Stock (INAB) Forecast
The In 8 Bio Inc (INAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.244, representing a +1,414% increase from the current price of $0.1482. The highest analyst price target is $2.3069, and the lowest is $2.1811.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INAB Price Target
Average 1.3481
(+809.66% Upside)
Is In 8 Bio Inc (INAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.57 | Buy |
| STOCH(9,6) | 10.20 | Buy |
| STOCHRSI(14) | 6.9706 | Buy |
| MACD(12,26) | -0.027 | Sell |
| ADX(14) | 27.30 | Sell |
| William %R | -90.09 | Buy |
| CCI(14) | -109.81 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1801
Sell
|
0.1769
Sell
|
| MA20 |
0.2064
Sell
|
0.1996
Sell
|
| MA50 |
0.2445
Sell
|
0.2352
Sell
|
| MA100 |
0.2724
Sell
|
0.2873
Sell
|
| MA200 |
0.4017
Sell
|
0.4566
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, INAB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on INAB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.57 indicates that INAB is oversold. This indicates that INAB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 10.2 indicates that INAB is oversold. This indicates that INAB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.9706 indicates that INAB is oversold. This suggests that INAB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.3 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -109.81 indicates that INAB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term INAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about In 8 Bio Inc financial reports and earnings history, In 8 Bio Inc (INAB) stock could reach $0.9983 by 2030, $21.72 by 2040 and $10.57 by 2050. See the projected annual prices until 2050 of the In 8 Bio Inc stock below:
- In 8 Bio Inc (INAB) is expected to reach an average price of $8.5343 in 2035, with a high prediction of $8.8718 and a low estimate of $8.5883. This indicates an $5,659% rise from the last recorded price of $0.1482.
- In 8 Bio Inc (INAB) stock is projected to chart a bullish course in 2040, with an average price target of $20.35, representing an $13,632% surge from its current level. The forecast ranges from a conservative $20.94 to a sky-high $21.72.
- Our analysts predict In 8 Bio Inc (INAB) to jump 26,688% by 2045, soaring from $40.23 to an average price of $39.70, potentially reaching $39.98. While $40.23 is the low estimate, the potential upside is significant.
- In 8 Bio Inc (INAB) stock is expected to climb by 2050, reaching an average of $9.4929, a $6,305% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.57 and $9.5729, respectively, highlighting the market's uncertainty.
In 8 Bio Inc Stock (INAB) Year by Year Forecast
In 8 Bio Inc Stock (INAB) Price Forecast for 2025
In 8 Bio Inc Stock (INAB) is expected to reach an average price of $2.1932 in 2025, with a high prediction of $2.9885 and a low estimate of $1.3979. This indicates an +1,380% rise from the last recorded price of $0.1482.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $2.3398 | $2.1811 | $2.3069 | +1,479% |
| June, 2025 | $2.3214 | $2.4114 | $2.4485 | +1,466% |
| July, 2025 | $2.3459 | $2.4493 | $2.4731 | +1,483% |
| August, 2025 | $2.1676 | $1.8317 | $2.0276 | +1,363% |
| September, 2025 | $1.4692 | $1.5663 | $1.5505 | +891.35% |
| October, 2025 | $1.651 | $1.3979 | $1.4737 | +1,014% |
| November, 2025 | $2.1853 | $2.0224 | $1.9345 | +1,375% |
| December, 2025 | $2.0599 | $2.1099 | $2.0745 | +1,290% |
In 8 Bio Inc Stock (INAB) Price Forecast for 2026
The predicted value for In 8 Bio Inc (INAB) in 2026 is set at an average of $1.0479. Estimates vary from a peak of $1.8728 to a trough of $0.2231, indicating an +607.10% surge from the present price of $0.1482.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.7715 | $0.9814 | $1.8728 | +420.56% |
| February, 2026 | $0.1769 | $0.2231 | $0.3956 | +19.37% |
| March, 2026 | $1.2847 | $0.8459 | $0.8647 | +766.88% |
| April, 2026 | $1.4592 | $1.1405 | $1.3392 | +884.64% |
| May, 2026 | $1.4609 | $1.408 | $1.3251 | +885.74% |
| June, 2026 | $1.4225 | $1.3667 | $1.3067 | +859.84% |
| July, 2026 | $1.1711 | $1.2585 | $1.1645 | +690.22% |
| August, 2026 | $0.9686 | $1.0444 | $1.1099 | +553.60% |
| September, 2026 | $0.8332 | $0.9847 | $1.0183 | +462.18% |
| October, 2026 | $0.2848 | $0.4548 | $0.6939 | +92.16% |
| November, 2026 | $0.2264 | $0.257 | $0.2923 | +52.76% |
| December, 2026 | $0.2309 | $0.2993 | $0.248 | +55.82% |
In 8 Bio Inc Stock (INAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for In 8 Bio Inc (INAB) is $4.3195, with a high forecast of $8.6355 and a low forecast of $0.00342. This indicates an +2,815% increase from the last price of $0.1482.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0475 | $0.0325 | $0.1833 | -67.98% |
| February, 2027 | $0.0142 | $0.00465 | $0.1386 | -90.44% |
| March, 2027 | $4.4158 | $0.00342 | $4.9201 | +2,880% |
| April, 2027 | $6.9491 | $5.9716 | $5.8032 | +4,589% |
| May, 2027 | $7.8623 | $6.6749 | $5.7507 | +5,205% |
| June, 2027 | $8.5113 | $8.1781 | $8.6355 | +5,643% |
| July, 2027 | $7.2446 | $7.7303 | $8.0572 | +4,788% |
| August, 2027 | $8.3678 | $7.3104 | $7.8258 | +5,546% |
| September, 2027 | $7.4362 | $7.4511 | $7.5753 | +4,918% |
| October, 2027 | $7.8401 | $7.6985 | $7.8943 | +5,190% |
| November, 2027 | $7.6734 | $8.3034 | $8.1873 | +5,078% |
| December, 2027 | $7.7324 | $7.7374 | $7.7324 | +5,118% |
In 8 Bio Inc Stock (INAB) Price Forecast for 2028
In 2028, In 8 Bio Inc (INAB) is projected to reach an average price of $5.4864, with a high projection of $7.3782 and a low estimate of $3.5946. This indicates an +3,602% rise from the last price of $0.1482.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.1157 | $7.4557 | $7.3782 | +4,701% |
| February, 2028 | $7.3989 | $7.4415 | $7.2389 | +4,893% |
| March, 2028 | $6.998 | $6.7121 | $6.6063 | +4,622% |
| April, 2028 | $7.2112 | $6.8796 | $6.7638 | +4,766% |
| May, 2028 | $6.8903 | $6.6828 | $6.757 | +4,549% |
| June, 2028 | $5.6635 | $5.8435 | $6.5962 | +3,722% |
| July, 2028 | $4.8967 | $5.4867 | $5.9651 | +3,204% |
| August, 2028 | $4.9358 | $5.0758 | $5.1443 | +3,230% |
| September, 2028 | $5.529 | $5.3574 | $5.464 | +3,631% |
| October, 2028 | $5.5323 | $5.5148 | $5.4557 | +3,633% |
| November, 2028 | $4.9313 | $5.0213 | $5.2881 | +3,227% |
| December, 2028 | $3.2846 | $3.5946 | $3.7671 | +2,116% |
In 8 Bio Inc Stock (INAB) Price Forecast for 2029
The 2029 price forecast for In 8 Bio Inc Stock (INAB) is $2.5646 on average, with a high prediction of $3.9785 and a low estimate of $1.1508. This represents an +1,631% increase from the previous price of $0.1482.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.8236 | $3.1962 | $3.5936 | +2,480% |
| February, 2029 | $3.7469 | $3.891 | $3.8552 | +2,428% |
| March, 2029 | $3.9601 | $3.9902 | $3.9785 | +2,572% |
| April, 2029 | $3.7733 | $3.7833 | $3.8159 | +2,446% |
| May, 2029 | $3.5124 | $3.5224 | $3.6793 | +2,270% |
| June, 2029 | $3.1857 | $3.2556 | $3.3215 | +2,050% |
| July, 2029 | $3.1389 | $3.0531 | $2.9914 | +2,018% |
| August, 2029 | $2.2579 | $2.3179 | $2.9157 | +1,424% |
| September, 2029 | $1.8612 | $1.9212 | $1.9237 | +1,156% |
| October, 2029 | $1.7202 | $1.7502 | $1.7171 | +1,061% |
| November, 2029 | $1.2335 | $1.4435 | $1.626 | +732.30% |
| December, 2029 | $1.1367 | $1.1508 | $1.1193 | +667.01% |
In 8 Bio Inc Stock (INAB) Price Forecast for 2030
In 8 Bio Inc Stock (INAB) is expected to reach an average price of $7.7503 in 2030, with a high forecast of $14.61 and a low forecast of $0.8873. This signifies an +5,130% surge from the last price of $0.1482.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.9428 | $0.8873 | $0.9983 | +536.17% |
| February, 2030 | $12.30 | $12.01 | $12.06 | +8,197% |
| March, 2030 | $12.46 | $12.91 | $12.11 | +8,308% |
| April, 2030 | $14.11 | $12.86 | $13.45 | +9,418% |
| May, 2030 | $13.41 | $14.55 | $14.61 | +8,948% |
| June, 2030 | $12.92 | $13.05 | $12.94 | +8,621% |
| July, 2030 | $13.16 | $13.46 | $13.47 | +8,778% |
| August, 2030 | $13.75 | $12.95 | $12.62 | +9,180% |
| September, 2030 | $13.35 | $13.65 | $13.31 | +8,906% |
| October, 2030 | $12.72 | $13.11 | $13.39 | +8,484% |
| November, 2030 | $12.54 | $12.67 | $12.71 | +8,359% |
| December, 2030 | $12.41 | $12.23 | $12.00 | +8,274% |
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):